This cluster reflects routine option exercise and diversification activity by executives, not a signal of fundamental concern. Traders should monitor for any follow-up filings or news around earnings or pipeline updates, but no immediate action is warranted based on this activity.
Price Chart
Executive Summary
Multiple C-suite executives at Acadia Pharmaceuticals, including the CEO, CFO, and other senior officers, conducted open-market share sales totaling approximately $504,000 over a two-day period, concurrent with the exercise of stock options. The sales represent a coordinated liquidity event following derivative exercises, but the dollar amount is small relative to the company's $3.8B market cap.
Key Financial Metrics
Key Facts
- CEO Catherine Owen Adams sold $249,932 worth of shares, CFO Mark Schneyer sold $158,332, and other C-suite executives sold an additional $95,766 in open-market transactions.
- All sales were preceded by or concurrent with the exercise of stock options (M-coded transactions), indicating pre-planned option monetization rather than discretionary selling of held shares.
- Total open-market sale value across all insiders: ~$504,000 over two days.
- Total value represents only 0.013% of Acadia's $3.8B market cap — well below the 0.1% threshold for materiality.
- No negative corporate news or guidance changes were reported alongside these transactions.
Financial Impact
$504,000 in open-market sales over two days (0.013% of market cap)
Risk Factors
- Perception risk: Concentrated insider selling, even if routine, could be misinterpreted by retail investors as negative sentiment.
- Liquidity timing: If these sales were accelerated ahead of potential bad news, it could raise questions — though no such catalyst is currently evident.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-ACAD-1774569644055 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | 8-K | $27.52 $26.40 | ▼ −4.09% | ▼ −4.19% | $19.95 (−27.51%) |
Aug 17, 2026 6w ago | Institutional Cluster | $29.01 $29.65 | ▲ +2.21% | ▲ +3.40% | $19.95 (−31.23%) |
Aug 7, 2026 7w ago | Insider Cluster | $29.39 $29.01 | ▼ −1.29% | ▼ −1.25% | $19.95 (−32.12%) |
Jun 11, 2026 16w ago | Institutional Cluster | $21.39 $21.60 | ▼ −0.98% | ▼ −0.55% | $19.95 (+6.73%) |
May 6, 2026 21w ago | 8-K | $22.56 $22.18 | ▲ +1.68% | ▲ +3.19% | $19.95 (+11.57%) |
May 4, 2026 21w ago | Insider Cluster | $22.19 $21.80 | ▼ −1.76% | ▼ −4.69% | $19.95 (−10.09%) |
Mar 25, 2026 27w ago | Insider Cluster | $22.01 $22.32 | ▲ +1.41% | ▲ +1.65% | $19.95 (−9.36%) |
Mar 5, 2026 30w ago | 8-K | $22.40 $21.27 | ▼ −5.04% | ▼ −2.81% | $19.95 (−10.94%) |
Feb 25, 2026 31w ago | 8-K | $24.64 $22.40 | ▼ −9.09% | ▼ −7.96% | $19.95 (−19.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access